首页|期刊导航|药物分析学报（英文）|The role of NRF2 in human cancers:Pre-clinical insights paving the way for clinical trials

The role of NRF2 in human cancers:Pre-clinical insights paving the way for clinical trials

Yi Pei Shengye Liu Jianqiao Yin Jiamei Liu Dongze Liu Qianlong Wu Xue Cai Mingming Han Yu Tian Liyu Yang

药物分析学报（英文）2026，Vol.16Issue(5)：1341-1358,18.

药物分析学报（英文）2026，Vol.16Issue(5)：1341-1358,18.DOI:10.1016/j.jpha.2025.101358

The role of NRF2 in human cancers:Pre-clinical insights paving the way for clinical trials

Yi Pei ¹Shengye Liu ²Jianqiao Yin ³Jiamei Liu ⁴Dongze Liu ²Qianlong Wu ²Xue Cai ⁵Mingming Han ⁶Yu Tian ⁷Liyu Yang²

作者信息

1. Department of Bone and Soft Tissue Surgery,Cancer Hospital of China Medical University||Liaoning Cancer Hospital & Institute,Shenyang,110042,China
2. Department of Orthopedics,Shengjing Hospital,China Medical University,Shenyang,110004,China
3. Department of Oncology,Shengjing Hospital,China Medical University,Shenyang,110004,China
4. Department of Pathology,Shengjing Hospital,China Medical University,Shenyang,110004,China
5. Department of Psychosomatic Medicine,The Huizhou Second People's Hospital,Huizhou,Guangdong,516001,China
6. Department of Pharmacy and Medical Devices,Shandong Academy of Occupational Health and Occupational Medicine,Occupational Disease Hospital of Shandong First Medical University(Shandong Province Hospital Occupational Disease Hospital),Jinan,250002,China
7. School of Public Health,Benedictine University,Lisle,IL,60532,USA||Research Center,The Huizhou Central People's Hospital,Guangdong Medical University,Huizhou,Guangdong,516001,China
折叠

摘要

关键词

NRF2/Cancer progression/Non-coding RNAs/Anti-cancer compounds/Targeted therapy

Key words

NRF2/Cancer progression/Non-coding RNAs/Anti-cancer compounds/Targeted therapy

引用本文复制引用

Yi Pei,Shengye Liu,Jianqiao Yin,Jiamei Liu,Dongze Liu,Qianlong Wu,Xue Cai,Mingming Han,Yu Tian,Liyu Yang..The role of NRF2 in human cancers:Pre-clinical insights paving the way for clinical trials[J].药物分析学报（英文）,2026,16(5):1341-1358,18.

基金项目

This research was supported by Liaoning Province Science and Technology Plan Joint Program(Natural Science Foundation-General Project)(2024-MSLH-559& 2024-MSLH-579),the Medical Engineering Interdisciplinary Research Funds of Liaoning Cancer Hospital & Institute-Dalian University of Technology under Grant No.LD202218,Collaborative Research Project of China Medical University,as well as the 345 Talent Project of Shengjing Hospital(30C&30D). （Natural Science Foundation-General Project）

药物分析学报（英文）

ISSN：2095-1779

访问量0

下载量0

段落导航